文献速递关节外科

解剖型有柄与无柄肩关节置换的长期生存与失败分析

Long-term survival and failure analysis of anatomical stemmed and stemless shoulder arthroplasties.
PubMed 文献 · Bone Joint J · 2021-01-01

本研究比较了有柄与无柄解剖型肩关节假体治疗肩骨关节炎的临床结果、长期生存率和并发症率。161例患者平均随访118个月,两组在Constant评分、DASH评分和活动度上均显著改善且组间无差异,十年累积生存率有柄组95.3%、无柄组91.5%,差异无统计学意义(p=0.251)。主要翻修原因均为与盂侧相关的并发症。

要点

  • 有柄与无柄解剖型肩关节假体在平均十年随访中临床结果无显著差异。
  • 十年累积生存率有柄组95.3%,无柄组91.5%,组间差异无统计学意义(p=0.251)。
  • 两种假体翻修的主要原因均为与盂侧相关的并发症。

核心结论

  • 解剖型无柄肩关节假体在平均十年随访中显示出良好可靠的结果,与有柄假体无差异。

研究设计与样本

  • 回顾性比较研究,纳入161例因原发性肩骨关节炎接受有柄或无柄解剖型肩关节置换的患者,平均随访118个月(102至158)。

主要发现

  • 两组术后活动度(p < 0.001)、Constant评分(p < 0.001)和DASH评分(p < 0.001)均显著改善。
  • 有柄组与无柄组平均Constant评分分别为79.2(35至118)和74.4(31至99),差异无统计学意义(p = 0.519)。
  • 有柄组与无柄组平均DASH评分分别为11.4(8至29)和13.2(7至23),差异无统计学意义(p = 0.210)。
  • 十年未调整累积生存率有柄组为95.3%,无柄组为91.5%,组间无差异(p = 0.251)。
  • 影像学评估显示两组肱骨假体均未出现松动,主要翻修原因均为与盂侧相关的并发症。

临床怎么用

  • 对于原发性肩骨关节炎,无柄解剖型肩关节假体可作为有柄假体的替代选择,长期生存和临床结果相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The purpose of this study was to compare clinical results, long-term survival, and complication rates of stemless shoulder prosthesis with stemmed anatomical shoulder prostheses for treatment of osteoarthritis and to analyze radiological bone changes around the implants during follow-up. METHODS: A total of 161 patients treated with either a stemmed or a stemless shoulder arthroplasty for primary osteoarthritis of the shoulder were evaluated with a mean follow-up of 118 months (102 to 158). The Constant score (CS), the Disabilities of the Arm, Shoulder and Hand (DASH) score, and active range of motion (ROM) were recorded. Radiological analysis for bone adaptations was performed by plain radiographs. A Kaplan-Meier survivorship analysis was calculated and complications were noted. RESULTS: The ROM (p < 0.001), CS (p < 0.001), and DASH score (p < 0.001) showed significant improvements after shoulder arthroplasty for both implants. There were no differences between the groups treated with stemmed or stemless shoulder prosthesis with respect to the mean CS (79.2 (35 to 118) vs 74.4 (31 to 99); p = 0.519) and DASH scores (11.4 (8 to 29) vs 13.2 (7 to 23); p = 0.210). The ten-year unadjusted cumulative survival rate was 95.3% for the stemmed anatomical shoulder prosthesis and 91.5% for the stemless shoulder prosthesis and did not differ between the treatment groups (p = 0.251). The radiological evaluation of the humeral components in both groups did not show loosening of the humeral implant. The main reason for revision for each type of arthroplasties were complications related to the glenoid. CONCLUSION: The use of anatomical stemless shoulder prosthesis yielded good and reliable results and did not differ from anatomical stemmed shoulder prosthesis over a mean period of ten years. The differences in periprosthetic humeral bone adaptations between both implants have no clinical impact during the follow-up. Cite this article: Bone Joint J 2021;103-B(7):1292-1300.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Märtens N, Heinze M, Awiszus F, et al. Long-term survival and failure analysis of anatomical stemmed and stemless shoulder arthroplasties. Bone Joint J. 2021. PMID: 34192923. doi:10.1302/0301-620X.103B7.BJJ-2020-0915.R3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。